Northpond Ventures
7500 OLD Georgetown RdBethesda, MD 20814
Firm Size
- Assets Under Management (AUM):$1.4 Billion
- Number of Funds:4
- Employees:
- Firm Type:Venture Capital
- Focus Areas:
Software & Technology
Healthcare
Description
Northpond Ventures, LLC is a venture capital firm based in Bethesda, Maryland. The firm primarily focuses on investing in early-stage companies in the healthcare and life sciences sector. Northpond Ventures aims to support innovative businesses that are driving advancements in biotechnology, pharmaceuticals, medical devices, and digital health solutions. With a team of experienced professionals, the firm provides both financial backing and strategic guidance to its portfolio companies. Overall, Northpond Ventures plays a crucial role in accelerating the growth and commercialization of groundbreaking technologies in the healthcare industry.Latest News
Powered by
Jan 23, 2024: Elephas Announces $55 Million in Series C Funding
Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $55 million in Series C funding. Venture Investors Health Fund and State of Wisconsin Investment Board (SWIB) led the round. Continuing investments were made by Northpond Ventures, ARCH Ventures, Sands Capital, Moore Strategic Ventures, Tao Invest, and WARF Ventures. With this $55 million Series C funding, this brings the total raised by Elephas to $116.5 million .
Aug 03, 2023: Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases, today announced the close of an oversubscribed $60 million Series B financing round extension, bringing the total Series B financing round to $145 million . New investors, Bain Capital Life Sciences and GordonMD® Global Investments LP, join existing investors Gilead Sciences, Westlake Village BioPartners, Vida Ventures, Northpond Ventures, RTW Investments, Insight Partners, CAM Capital, LYFE Capital, jVen Capital, and others.